ArticleACS chemical biology2026
A Modular Platform for Quantitative Two-Color Bioluminescence Combining NanoLuc and Red-Shifted NanoPrism Luciferases.
Article in ACS chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- PrismaLuc luciferase enables tunable near-infrared bioluminescence forRSC chemical biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bioluminescent reporters are widely used to monitor and image biological processes. Among these, NanoLuc luciferase and its complementation variants (LgBiT/SmBiT and LgBiT/HiBiT) are commonly used due to their brightness, sensitivity, and compatibility with prolonged kinetic measurements. However, the single-channel emission of these NanoLuc-based systems (460 nm peak) limits their use in multiplexed assays. Prior efforts to shift NanoLuc's emission employed bioluminescence resonance energy transfer (BRET) to a proximal fluorescent protein or organic fluorophore. Building on this concept, we engineered high-efficiency BRET reporters, termed NanoPrism luciferases, by inserting circularly permuted NanoLuc or LgBiT into a surface loop of the self-labeling HaloTag protein. These NanoPrisms achieve a ∼90% BRET efficiency by optimally positioning NanoLuc variants near a fluorophore covalently bound to HaloTag. The binary design further supports high- and low-affinity complementation, allowing applications in HiBiT knock-in cells and tracking protein-protein interactions, respectively. Pairing red-shifted NanoPrisms with unmodified NanoLuc or its complementation variants, we created a two-color bioluminescent reporter platform featuring bright signals of similar intensity and >100 nm spectral separation, allowing quantitative, simultaneous measurement of two molecular readouts within the same sample. Here, we demonstrate the platform's utility for monitoring a degradation target alongside a control protein and for tracking two distinct events within a biological pathway, using plate-based detection and bioluminescence imaging. By enabling concurrent measurements within the same sample, the system provides insights into cellular dynamics while reducing variability and complexity associated with parallel single-channel assays.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.